The Riverside Company / Clinical Education Alliance Acquires liV Inc.

The Riverside Company Acquires Clinical Education Alliance from Renovus Capital Partners

December 10, 2020

Healthcare Services

The Riverside Company has signed a definitive agreement to acquire a majority stake in Clinical Education Alliance (CEA), a Virginia-based provider of live and web-based continuing medical education (CME). Renovus Capital Partners sold its majority stake but will remain a minority investor; Riverside plans to expand CEA’s therapeutic areas, end-user base and technology offering to accelerate growth.

Clinical Education Alliance Acquires MDoutlook (Riverside Add-on)

July 29, 2021

Healthcare Services

Clinical Education Alliance (CEA), a Riverside-backed healthcare education platform, has acquired MDoutlook as an add-on to expand its precision intelligence and market research capabilities for healthcare professionals. The Riverside Company led the investment, combining CEA's large HCP network with MDoutlook's AI/ML-assisted expert database and market research services to broaden the platform's analytics and engagement offerings.

Clinical Education Alliance Acquires Rockpointe Corporation

July 26, 2022

Healthcare Services

Clinical Education Alliance (CEA), a Riverside-backed healthcare education platform, has acquired Rockpointe Corporation, a provider of accredited continuing education (CE) programs for healthcare professionals. The add-on expands CEA’s reach into primary care and community healthcare settings and strengthens its high-science therapeutic education capabilities.

The Riverside Company Invests in iCEV

December 14, 2021

Education

The Riverside Company has signed a definitive agreement to invest in iCEV, a Lubbock, Texas–based developer of SaaS-based digital curriculum, instructional materials and certification testing for the Career and Technical Education (CTE) market. Riverside said it will leverage its Education & Training platform to expand iCEV's content and capabilities through organic growth and M&A initiatives.

The Riverside Company Invests in Avance Clinical

November 9, 2021

Healthcare Services

The Riverside Company has invested in Avance Clinical, a leading Australian contract research organisation (CRO), to support the company's regional and international expansion. The investment will help Avance accelerate its clinical trials business — including vaccine and gene-technology studies — with a particular focus on growth in North America and Asia.

The Riverside Company Invests in CRIO, Inc.

May 21, 2024

Cloud & SaaS

The Riverside Company, via its Riverside Micro-Cap Fund, has made a growth investment in CRIO, Inc., a Boston-based provider of cloud-based eSource, CTMS and regulatory-compliance software for clinical trial sites, CROs and pharmaceutical/biotech sponsors. Riverside’s capital will support accelerated product development, broader product offerings and potential strategic acquisitions as CRIO scales.